BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 25874926)

  • 1. Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.
    Atashrazm F; Lowenthal RM; Woods GM; Holloway AF; Dickinson JL
    Mar Drugs; 2015 Apr; 13(4):2327-46. PubMed ID: 25874926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brown seaweed fucoidan: biological activity and apoptosis, growth signaling mechanism in cancer.
    Senthilkumar K; Manivasagan P; Venkatesan J; Kim SK
    Int J Biol Macromol; 2013 Sep; 60():366-74. PubMed ID: 23817097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles.
    Jin JO; Chauhan PS; Arukha AP; Chavda V; Dubey A; Yadav D
    Mar Drugs; 2021 May; 19(5):. PubMed ID: 34068561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
    Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
    Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells.
    Zhang Z; Teruya K; Yoshida T; Eto H; Shirahata S
    Mar Drugs; 2013 Jan; 11(1):81-98. PubMed ID: 23303302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucoidan as a marine anticancer agent in preclinical development.
    Kwak JY
    Mar Drugs; 2014 Jan; 12(2):851-70. PubMed ID: 24477286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor-bearing mice.
    Huang TH; Chiu YH; Chan YL; Chiu YH; Wang H; Huang KC; Li TL; Hsu KH; Wu CJ
    Mar Drugs; 2015 Apr; 13(4):1882-900. PubMed ID: 25854641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer combination therapies with artemisinin-type drugs.
    Efferth T
    Biochem Pharmacol; 2017 Sep; 139():56-70. PubMed ID: 28366726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance.
    Reyes ME; Riquelme I; Salvo T; Zanella L; Letelier P; Brebi P
    Mar Drugs; 2020 Apr; 18(5):. PubMed ID: 32354032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms.
    van Weelden G; Bobiński M; Okła K; van Weelden WJ; Romano A; Pijnenborg JMA
    Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30621045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines.
    Abudabbus A; Badmus JA; Shalaweh S; Bauer R; Hiss D
    Curr Pharm Biotechnol; 2017; 18(9):748-757. PubMed ID: 29141543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway.
    Rui X; Pan HF; Shao SL; Xu XM
    BMC Complement Altern Med; 2017 Aug; 17(1):378. PubMed ID: 28764703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucoidan from Turbinaria conoides: a multifaceted 'deliverable' to combat pancreatic cancer progression.
    Delma CR; Somasundaram ST; Srinivasan GP; Khursheed M; Bashyam MD; Aravindan N
    Int J Biol Macromol; 2015 Mar; 74():447-57. PubMed ID: 25541359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug-A Review.
    Jin JO; Yadav D; Madhwani K; Puranik N; Chavda V; Song M
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral administration of fucoidan extracted from Cladosiphon okamuranus on tumor growth and survival time in a tumor-bearing mouse model.
    Azuma K; Ishihara T; Nakamoto H; Amaha T; Osaki T; Tsuka T; Imagawa T; Minami S; Takashima O; Ifuku S; Morimoto M; Saimoto H; Kawamoto H; Okamoto Y
    Mar Drugs; 2012 Oct; 10(10):2337-2348. PubMed ID: 23170088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Different Molecular Weight Fucoidan Fractions Derived from New Zealand
    Yang X; Wang S; Trangle SS; Li Y; White WL; Li J; Ying T; Kong Q; Zhao Y; Lu J
    Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30453677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel fucoidan based bioactive targeted nanoparticles from Undaria Pinnatifida for treatment of pancreatic cancer.
    Etman SM; Abdallah OY; Elnaggar YSR
    Int J Biol Macromol; 2020 Feb; 145():390-401. PubMed ID: 31881303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on fucoidan antitumor strategies: From a biological active agent to a structural component of fucoidan-based systems.
    Oliveira C; Neves NM; Reis RL; Martins A; Silva TH
    Carbohydr Polym; 2020 Jul; 239():116131. PubMed ID: 32414455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro anticancer activity of fucoidan from Turbinaria conoides against A549 cell lines.
    Marudhupandi T; Ajith Kumar TT; Lakshmanasenthil S; Suja G; Vinothkumar T
    Int J Biol Macromol; 2015 Jan; 72():919-23. PubMed ID: 25451746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of human malignant lymphoid cells to etoposide by fucoidan, a brown seaweed polysaccharide.
    Philchenkov A; Zavelevich M; Imbs T; Zvyagintseva T; Zaporozhets T
    Exp Oncol; 2007 Sep; 29(3):181-5. PubMed ID: 18004241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.